Evolva AG is a Swiss biotech company focused on the research, development, and commercialization of natural ingredients using advanced yeast fermentation technologies. Its primary markets include flavors and fragrances, health ingredients, and cosmetics. Evolva's core products include resveratrol (Veri-te), nootkatone, and valencene, used in various sectors such as nutrition, cosmetics, and fragrances. The company was acquired by Lallemand Inc. in December 2023, allowing for further global expansion through Lallemand's extensive network.